We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-14 of 14 results
  1. The impact of the histone deacetylase inhibitor sodium butyrate on microglial polarization after oxygen and glucose deprivation

    Background

    Microglia play a major role in the development of brain inflammation after central nervous system injury. On the other hand, microglia also...

    Karolina Ziabska, Justyna Gargas, ... Malgorzata Ziemka-Nalecz in Pharmacological Reports
    Article 07 July 2022
  2. Pharmacological Strategies to Overcome Tumor Resistance to Anticancer Hormonal, Targeted, and Immunotherapy

    Possible molecular mechanisms of develo** tumor drug resistance to anticancer hormonal, targeted, and immunotherapy that are associated with the...

    T. A. Fedotcheva, N. L. Shimanovsky in Pharmaceutical Chemistry Journal
    Article 25 May 2023
  3. The role and application of transcriptional repressors in cancer treatment

    Gene expression is modulated through the integration of many regulatory elements and their associated transcription factors (TFs). TFs bind to...

    Miso Park, Keon Wook Kang, Ji Won Kim in Archives of Pharmacal Research
    Article 16 January 2023
  4. The role of epithelial–mesenchymal transition-regulating transcription factors in anti-cancer drug resistance

    The complex orchestration of gene expression that mediates the transition of epithelial cells into mesenchymal cells is implicated in cancer...

    Jihye Seo, Jain Ha, ... Sayeon Cho in Archives of Pharmacal Research
    Article Open access 25 March 2021
  5. Histone deacetylases (HDACs) as therapeutic target for depressive disorders

    Major depressive disorder (MDD) represents approximately 40% of the disability caused by mental illnesses globally. The poorly understood...

    Paulina Misztak, Patrycja Pańczyszyn-Trzewik, Magdalena Sowa-Kućma in Pharmacological Reports
    Article 12 August 2017
  6. Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future

    Background

    Duchenne muscular dystrophy (DMD) is a severe X-linked neuromuscular childhood disorder that causes progressive muscle weakness and...

    Agnieszka Łoboda, Józef Dulak in Pharmacological Reports
    Article Open access 20 July 2020
  7. Targeting ROCK/LIMK/cofilin signaling pathway in cancer

    Rho-associated coiled-coil-containing protein kinase (ROCK)/Lin11, Isl-1 and Mec-3 kinase (LIMK)/cofilin-signaling cascades are stimulated by...

    Mee-Hyun Lee, Joydeb Kumar Kundu, ... Jung-Hyun Shim in Archives of Pharmacal Research
    Article 27 April 2019
  8. Role of autophagy in regulation of cancer cell death/apoptosis during anti-cancer therapy: focus on autophagy flux blockade

    Autophagy is a self-degradation process in which the cytoplasmic cargoes are delivered to the lysosomes for degradation. As the cargoes are...

    Nirmala Tilija Pun, Won-Jun Jang, Chul-Ho Jeong in Archives of Pharmacal Research
    Article 26 May 2020
  9. Barriers for Pharmaceutical Innovation With Focus in Cancer Drugs, the Case of Mexico

    Drug innovation does not only generate economic growth but also portrays a country’s efforts toward innovation. The article reviews the current...

    Alfonso Duenas-Gonzalez, Aurora Gonzalez-Fierro in Therapeutic Innovation & Regulatory Science
    Article 06 January 2020
  10. Sulforaphane as an anticancer molecule: mechanisms of action, synergistic effects, enhancement of drug safety, and delivery systems

    Sulforaphane is an isothiocyanate compound that has been derived from cruciferous vegetables. It was shown in numerous studies to be active against...

    Mohammad M. Kamal, Sharmin Akter, ... Sami Nazzal in Archives of Pharmacal Research
    Article 10 March 2020
  11. Strategy for enhancing the therapeutic efficacy of histone deacetylase inhibitor dacinostat: the novel paradigm to tackle monotonous cancer chemoresistance

    Histone deacetylases (HDACs) regulate gene expression by creating the closed state of chromatin via histone hypoacetylation. Histone acetylation...

    Shabir Ahmad Ganai in Archives of Pharmacal Research
    Article 19 October 2015
  12. Suppression of T cell functions by hydroxamic acid-based histone deacetylase inhibitors

    Histone deacetylase inhibitors (HDACis) have recently been shown to suppress inflammatory responses at much lower concentrations than that the...

    Young Hoon Kim, Jae Kwon Lee in Archives of Pharmacal Research
    Article 29 May 2012
  13. An experimental study of rabbit conjunctival epithelial toxicity using co-treatment with Mitomycin-C and a histone deacetylase inhibitor

    This study was conducted to evaluate cytotoxicity due to co-treatment with low-dose Mitomycin-C (MMC) and the histone deacetylase inhibitor,...

    Tae-Hyun Kim, Hyun Cheol Oh, ... Sae Heun Rho in Archives of Pharmacal Research
    Article 28 August 2010
  14. Pharmocoepigenetics: a new approach to predicting individual drug responses and targeting new drugs

    Epigenetics is the study of heritable changes in genes and gene expression that do not involve DNAnucleotide sequences. Epigenetic modifications...

    Wanda Baer-Dubowska, Aleksandra Majchrzak-Celińska, Michał Cichocki in Pharmacological Reports
    Article 01 March 2011
Did you find what you were looking for? Share feedback.